ChartMill assigns a Buy % Consensus number of 46% to AEMD. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2022-11-15 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-06-25 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-01 | HC Wainwright & Co. | Initiate | Buy |
7 analysts have analysed AEMD and the average price target is 12.62 USD. This implies a price increase of 240.23% is expected in the next year compared to the current price of 3.71.
The consensus rating for AETHLON MEDICAL INC (AEMD) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering AETHLON MEDICAL INC (AEMD) is 7.